Related references
Note: Only part of the references are listed.Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations
Angelique Gougelet et al.
GUT (2016)
MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice
Alessandra Tessitore et al.
BMC CANCER (2016)
Population Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States
Oxana V. Makarova-Rusher et al.
CANCER (2016)
Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-B in hepatocellular carcinoma
Daisy P. F. Tsang et al.
JOURNAL OF PATHOLOGY (2016)
Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma
Marta B. Afonso et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma
Yuan Tian et al.
CANCER RESEARCH (2015)
Reduced Histone H3 Acetylation in CD4+ T Lymphocytes: Potential Mechanism of Latent Autoimmune Diabetes in Adults
Xi-yu Liu et al.
DISEASE MARKERS (2015)
A CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patients
Hai Feng et al.
JOURNAL OF HEPATOLOGY (2015)
miR-122-A key factor and therapeutic target in liver disease
Simonetta Bandiera et al.
JOURNAL OF HEPATOLOGY (2015)
CUL4B activates Wnt/beta-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists
Jupeng Yuan et al.
JOURNAL OF PATHOLOGY (2015)
CUL4B: a novel epigenetic driver in Wnt/β-catenin-dependent hepatocarcinogenesis
Myth T. S. Mok et al.
JOURNAL OF PATHOLOGY (2015)
Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma
Hamza Chettouh et al.
LIVER INTERNATIONAL (2015)
Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma
Wei Kang et al.
MOLECULAR CANCER (2015)
Erratum: Advances in targeted therapies for hepatocellular carcinoma in the genomic era
Josep M. Llovet et al.
Nature Reviews Clinical Oncology (2015)
Noncoding RNA as Therapeutic Targets for Hepatocellular Carcinoma
Joseph George et al.
SEMINARS IN LIVER DISEASE (2015)
Epigenetic modifiers in normal and malignant hematopoiesis
Jessica N. Haladyna et al.
EPIGENOMICS (2015)
Targeting hypoxia-inducible factor-2α enhances sorafenib antitumor activity via β-catenin/C-Myc-dependent pathways in hepatocellular carcinoma
Feng Liu et al.
ONCOLOGY LETTERS (2015)
Epigenetic Silencing of miR-490-3p Reactivates the Chromatin Remodeler SMARCD1 to Promote Helicobacter pylori-Induced Gastric Carcinogenesis
Jing Shen et al.
CANCER RESEARCH (2015)
Episensitization: Therapeutic Tumor Resensitization by Epigenetic Agents: A Review and Reassessment
Bryan Oronsky et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2014)
MiRNA-145 is involved in the development of resistin-induced insulin resistance in HepG2 cells
Fengyun Wen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Promoter Methylation of SFRP3 Is Frequent in Hepatocellular Carcinoma
Ya-Wen Lin et al.
DISEASE MARKERS (2014)
Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition
H. Quan et al.
ONCOGENE (2014)
Depletion of Sirtuin 1 (SIRT1) Leads to Epigenetic Modifications of Telomerase (TERT) Gene in Hepatocellular Carcinoma Cells
Bin Zhang et al.
PLOS ONE (2014)
Sox17 Regulates Insulin Secretion in the Normal and Pathologic Mouse β Cell
Diva Jonatan et al.
PLOS ONE (2014)
DNA Methylation Analysis in Nonalcoholic Fatty Liver Disease Suggests Distinct Disease-Specific and Remodeling Signatures after Bariatric Surgery
Markus Ahrens et al.
CELL METABOLISM (2013)
Inhibition of Class I Histone Deacetylases Unveils a Mitochondrial Signature and Enhances Oxidative Metabolism in Skeletal Muscle and Adipose Tissue
Andrea Galmozzi et al.
DIABETES (2013)
Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma
Xiaomei Zhang et al.
EPIGENETICS (2013)
Relationship Between Methylome and Transcriptome in Patients With Nonalcoholic Fatty Liver Disease
Susan K. Murphy et al.
GASTROENTEROLOGY (2013)
Medical therapies for hepatocellular carcinoma: a critical view of the evidence
Augusto Villanueva et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Deep Sequencing of Small RNA Repertoires in Mice Reveals Metabolic Disorders-Associated Hepatic miRNAs
Tingming Liang et al.
PLOS ONE (2013)
Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease
Yuan Tian et al.
SEMINARS IN CANCER BIOLOGY (2013)
Cancer Epigenetics: From Mechanism to Therapy
Mark A. Dawson et al.
CELL (2012)
The Genetic and Epigenetic Basis of Type 2 Diabetes and Obesity
A. W. Drong et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography
Vincent Wai-Sun Wong et al.
GUT (2012)
NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications
Geoffrey C. Farrell et al.
GUT AND LIVER (2012)
Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma
Ole Ammerpohl et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
Shu-hao Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Transition from hepatic steatosis to steatohepatitis: Unique microRNA patterns and potential downstream functions and pathways
Xi Jin et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/ß-catenin pathway
Jie Xu et al.
LIVER INTERNATIONAL (2012)
Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration
Zheng Sun et al.
NATURE MEDICINE (2012)
MicroRNAs in metabolism and metabolic disorders
Veerle Rottiers et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
DNA Methylation Patterns in Cord Blood DNA and Body Size in Childhood
Caroline L. Relton et al.
PLOS ONE (2012)
Correction: MiR-214 Targets β-Catenin Pathway to Suppress Invasion, Stem-Like Traits and Recurrence of Human Hepatocellular Carcinoma
Hongping Xia et al.
PLoS One (2012)
Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma
Pushpinder Kaur et al.
TUMOR BIOLOGY (2012)
EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin-Dependent Hepatocarcinogenesis
Alfred S. L. Cheng et al.
CANCER RESEARCH (2011)
The Natural History of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis or Cirrhosis: An International Collaborative Study
Neeraj Bhala et al.
HEPATOLOGY (2011)
MicroRNAs 103 and 107 regulate insulin sensitivity
Mirko Trajkovski et al.
NATURE (2011)
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
Katey J. Rayner et al.
NATURE (2011)
Obesity-induced over expression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism
Sabine D. Jordan et al.
NATURE CELL BIOLOGY (2011)
Carboxyl-Terminal Truncated HBx Regulates a Distinct MicroRNA Transcription Program in Hepatocellular Carcinoma Development
Wing-Kit Yip et al.
PLOS ONE (2011)
A Circadian Rhythm Orchestrated by Histone Deacetylase 3 Controls Hepatic Lipid Metabolism
Dan Feng et al.
SCIENCE (2011)
SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma
Yan Jia et al.
EPIGENETICS (2010)
MicroRNA-370 controls the expression of MicroRNA-122 and Cpt1α and affects lipid metabolism
Dimitrios Iliopoulos et al.
JOURNAL OF LIPID RESEARCH (2010)
Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis
Lifeng Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells
Jun Cheng et al.
PROTEOMICS (2010)
Robe of Cyclin D1 as a Mediator of c-Met- and beta-Catenin-Induced Hepatocarcinogenesis
Mohini A. Patil et al.
CANCER RESEARCH (2009)
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
Bryan T. MacDonald et al.
DEVELOPMENTAL CELL (2009)
Epigenetic disruption of the WNT/β-catenin signaling pathway in human cancers
Ying Ying et al.
EPIGENETICS (2009)
Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet
Igor P. Pogribny et al.
JOURNAL OF HEPATOLOGY (2009)
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
Man-Fung Yuen et al.
JOURNAL OF HEPATOLOGY (2009)
DACT3 is an epigenetic regulator of Wnt/β-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications
Xia Jiang et al.
CANCER CELL (2008)
Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest
Fang Sun et al.
FEBS LETTERS (2008)
Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma
Hideyasu Takagi et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology
Theresa Alenghat et al.
NATURE (2008)
Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation
Yutaka Kondo et al.
NATURE GENETICS (2008)
WNT10B functional dualism:: β-Catenin/Tcf-dependent growth promotion or independent suppression with deregulated expression in cancer
Hirohide Yoshikawa et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
β-Catenin destruction complex:: insights and questions from a structural perspective
D. Kimelman et al.
ONCOGENE (2006)
Mining the Wnt pathway for cancer therapeutics
Nick Barker et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
Prickle-1 negatively regulates Wnt/β-catenin pathway by promoting dishevelled ubiquitination/degraclation in liver cancer
David W. Chan et al.
GASTROENTEROLOGY (2006)
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
SB Baylin et al.
NATURE REVIEWS CANCER (2006)
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
C Esau et al.
CELL METABOLISM (2006)
Secreted antagonists of the Wnt signalling pathway
Y Kawano et al.
JOURNAL OF CELL SCIENCE (2003)
Wnt signaling in hepatocellular carcinoma: Analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes
J Cui et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
Dapper, a Dishevelled-associated antagonist of β-catenin and JNK signaling, is required for notochord formation
BNR Cheyette et al.
DEVELOPMENTAL CELL (2002)
Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism
CM Liu et al.
CELL (2002)
Share Paper
